Randi Gron

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial.

The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial.

Journal: Journal of diabetes science and technology

Published: February 29, 2020

IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.

IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.

Journal: Diabetes, obesity & metabolism

Published: May 10, 2019

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.

Journal: The lancet. Diabetes & endocrinology

Published: April 15, 2019

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).

Journal: Diabetes, obesity & metabolism

Published: November 13, 2018

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.

Journal: Diabetes care

Published: June 05, 2017

Active smoking and risk of breast cancer in a Danish nurse cohort study.

Active smoking and risk of breast cancer in a Danish nurse cohort study.

Journal: BMC cancer

Published: July 19, 2016

Misspecified poisson regression models for large-scale registry data: inference for 'large n and small p'.

Misspecified poisson regression models for large-scale registry data: inference for 'large n and small p'.

Journal: Statistics in medicine

Published: October 29, 2014

Authors' reply.

Authors' reply.

Journal: The British journal of psychiatry : the journal of mental science

Published: July 25, 2013

Maternal depression, antidepressant use in pregnancy and Apgar scores in infants.

Maternal depression, antidepressant use in pregnancy and Apgar scores in infants.

Journal: The British journal of psychiatry : the journal of mental science

Published: February 23, 2013

Risk factors for venous thromboembolism during pregnancy.

Risk factors for venous thromboembolism during pregnancy.

Journal: Pharmacoepidemiology and drug safety

Published: December 15, 2012

The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age.

The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age.

Journal: Psychopharmacology

Published: December 10, 2012

Nonparametric estimation in an "illness-death" model when all transition times are interval censored.

Nonparametric estimation in an "illness-death" model when all transition times are interval censored.

Journal: Biometrical journal. Biometrische Zeitschrift

Published: June 28, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026